세계의 DNA 및 RNA 뱅킹 서비스 시장

Global DNA & RNA Banking Services Market to Reach US$11.5 Billion by 2030

The global market for DNA & RNA Banking Services estimated at US$8.6 Billion in the year 2024, is expected to reach US$11.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Transportation Service, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Processing Service segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 4.8% CAGR

The DNA & RNA Banking Services market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global DNA & RNA Banking Services Market - Key Trends & Drivers Summarized

Is the Surge in Genomic Research Revolutionizing the DNA & RNA Banking Landscape?

The exponential growth in genomic research and its expanding role in personalized medicine have become the cornerstone driving the rapid evolution of DNA and RNA banking services globally. As the fields of genomics, transcriptomics, and pharmacogenomics continue to flourish, the demand for high-quality, well-preserved nucleic acid samples has surged. Institutions involved in drug discovery, disease modeling, and biomarker identification rely heavily on biobanks that offer secure, long-term storage of genetic material. DNA and RNA banking services have thus emerged as a critical support infrastructure for researchers, healthcare providers, and biotechnology firms. This surge is also influenced by the increasing need for population-scale genomic databases that help identify genetic predispositions to chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions. Governments and private organizations alike are investing in large-scale biobanking initiatives to collect and analyze genetic information across diverse populations. These services provide standardized protocols for sample collection, processing, storage, and retrieval-ensuring the integrity and reproducibility of research findings. Additionally, the COVID-19 pandemic underscored the importance of rapid genomic surveillance and highlighted the need for robust RNA preservation systems, further emphasizing the critical role these services play. As a result, biobanking facilities are now being designed with advanced automation, cryogenic storage capabilities, and digital inventory management systems to meet the rising expectations for speed, security, and scalability. The convergence of precision medicine, artificial intelligence, and genomics continues to push the boundaries of data-driven healthcare, making DNA and RNA banking a central pillar in the biomedical innovation ecosystem.

Are Evolving Data Security Norms and Ethical Considerations Reshaping Service Models?

As the volume and sensitivity of stored genetic material increase, so do concerns around data security, ethical governance, and patient consent-factors that are reshaping how DNA and RNA banking services operate. The inherently personal and immutable nature of genetic data raises significant questions about privacy, ownership, and misuse, prompting regulatory authorities worldwide to strengthen compliance frameworks. Legislation such as the General Data Protection Regulation (GDPR) in Europe and HIPAA in the U.S. impose strict guidelines on the collection, storage, and usage of genetic material, requiring service providers to implement robust data encryption, access controls, and traceability protocols. Moreover, ethical biobanking now demands dynamic consent models, where participants are continually informed about how their samples are being used, and can opt in or out of specific research initiatives. These changes are encouraging the adoption of blockchain-based data management systems and biometric authentication to ensure sample provenance and protect against unauthorized access. Service providers are also investing in staff training and institutional review board (IRB) collaborations to ensure that ethical standards are embedded throughout the sample life cycle. Additionally, there's a rising trend toward community engagement and transparency in research outcomes, especially when collecting samples from indigenous or underrepresented populations. This ethical evolution is not merely a compliance exercise but a strategic imperative-institutions that prioritize ethical integrity and data security are increasingly viewed as more credible and desirable partners for international research collaborations and funding opportunities. These dynamics are not only transforming service delivery models but are also elevating the strategic value of DNA and RNA banking services in the broader research and diagnostics supply chain.

Is Commercialization Driving Innovation and Accessibility in Biobanking Services?

The DNA and RNA banking market is undergoing a profound shift from academic and institutional dominance toward a more commercial, service-oriented model that is making biobanking more accessible and dynamic. Historically, biobanks were primarily affiliated with academic research centers and government institutions, but the growing commercial interest in genetic data has led to the emergence of private biobanking companies offering scalable and on-demand storage services. These services are increasingly tailored for a broad array of clients-including pharmaceutical companies, contract research organizations (CROs), fertility clinics, and even direct-to-consumer (DTC) genetic testing firms. This commercialization wave is driving investments into state-of-the-art storage technologies such as vapor-phase liquid nitrogen systems, automated sample retrieval robotics, and integrated laboratory information management systems (LIMS). Moreover, biobanking services are being bundled with value-added solutions like nucleic acid extraction, quality control assays, data analytics, and even sample logistics management, offering a full-spectrum service ecosystem to clients. Cloud-based sample tracking platforms now enable real-time inventory access, while interoperability with research databases and electronic health records (EHRs) is improving sample utility in clinical applications. Cross-border collaborations and centralized biobanking networks are also gaining traction, allowing researchers to access geographically and ethnically diverse genetic repositories without logistical barriers. The competitive landscape is becoming increasingly innovation-driven, with market players differentiating through faster turnaround times, higher sample quality assurance, and customizable service models. This shift is democratizing access to high-quality biobanking services, enabling even small labs and startups to participate in cutting-edge genomic research without having to invest in their own storage infrastructure.

What Are the True Growth Catalysts Behind the DNA & RNA Banking Services Market?

The growth in the DNA and RNA banking services market is driven by several factors grounded in scientific advancements, evolving end-user needs, and technological infrastructure. Foremost, the surge in genomic and transcriptomic research across academic, clinical, and commercial settings is creating consistent demand for secure and scalable storage of nucleic acids. This demand is magnified by the widespread adoption of next-generation sequencing (NGS) and other high-throughput molecular biology techniques that generate vast volumes of genetic material requiring long-term preservation. Additionally, pharmaceutical and biotech companies are leveraging these services to build comprehensive genetic datasets that support targeted drug development and personalized therapy approaches. Another crucial driver is the increasing reliance on biobanked samples in large-scale epidemiological studies and national genome initiatives that aim to decode genetic diversity and health patterns across populations. Furthermore, the growing use of RNA-based applications-such as mRNA vaccine development and transcriptomic profiling-has underscored the need for ultra-low temperature storage systems with strict RNA integrity preservation. Changing consumer behavior is also playing a role; the popularity of at-home genetic testing kits has led to a proliferation of consumer-generated samples requiring safe, long-term storage options, which has opened new avenues for biobanking services. At the technological level, the integration of AI and machine learning into biobank data management is enabling predictive analytics and smarter resource allocation. Finally, strategic collaborations between public health organizations, private service providers, and academic institutions are fostering standardized practices and broader global accessibility to stored genetic materials. These converging drivers are collectively shaping a resilient and fast-expanding market for DNA and RNA banking services, positioning it as a critical enabler of the next generation of healthcare and biomedical innovation.

SCOPE OF STUDY:

The report analyzes the DNA & RNA Banking Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage, Other Services); Specimen (Blood Specimen, Buccal Swabs & Hair Follicles Specimen, Other Specimens); Application (Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application, Other Applications); End-Use (Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

• 23andMe, Inc.
• AstridBio Ltd.
• Biomatrica, Inc.
• Brooks Life Sciences
• Coriell Institute for Medical Research
• deCODE genetics
• DNA Genotek Inc.
• EasyDNA
• Genetic Services of America
• GenVault Corporation
• GoodCell
• Infinity Biologix
• LGC Biosearch Technologies
• MedGenome Inc.
• National Center for Biotechnology Information (NCBI)
• PreventionGenetics
• ProteoGenex
• Qiagen N.V.
• Sampled (formerly RUCDR Infinite Biologics)
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • DNA & RNA Banking Services - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Focus on Genomic and Precision Medicine Throws the Spotlight on DNA & RNA Biobanking Needs
  • Surge in Population-Scale Genomic Initiatives Propels Growth in Long-Term Nucleic Acid Storage Demand
  • Integration of AI and Big Data Analytics Strengthens Business Case for Digitalized Biobanking Systems
  • Increasing Demand for High-Quality Biospecimens in Drug Discovery Expands Addressable Market Opportunity
  • Widespread Adoption of Personalized Therapies Drives Adoption of Patient-Centric DNA & RNA Sample Repositories
  • Growing Role of Biobanks in Translational Research Accelerates Demand for Multi-Omics Sample Storage Infrastructure
  • Expansion of Clinical Trials and Biomarker Research Spurs Use of DNA & RNA Banking Across Pharma Pipelines
  • Advancements in Cryopreservation and Sample Handling Technologies Enhance Reliability and Long-Term Storage Viability
  • Growing Emphasis on Ethical Consent and Data Governance Strengthens Compliance-Driven Biobanking Models
  • Rise in Infectious Disease Surveillance and Pandemic Preparedness Generates Demand for RNA Sample Archiving
  • Outsourcing Trends Among CROs and Academic Institutions Sustain Growth of Commercial Biobanking Services
  • Demand for Standardized Protocols and Global Interoperability Drives Industry-Wide Harmonization Efforts
  • Shift Toward Integrated Biobank Networks and Cloud-Linked Repositories Expands Scalability and Access
  • Use of Blockchain and Secure Access Tools Enhances Trust and Transparency in Genomic Data Storage Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World DNA & RNA Banking Services Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for DNA & RNA Banking Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Transportation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Processing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Processing Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Storage Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Storage Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Quality Control Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Quality Control Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Data Storage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Data Storage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Therapeutics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World 6-Year Perspective for Therapeutics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Drug Discovery & Clinical Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 19: World 6-Year Perspective for Drug Discovery & Clinical Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World 6-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 24: World Recent Past, Current & Future Analysis for Academic Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 25: World 6-Year Perspective for Academic Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World 6-Year Perspective for Hospitals & Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 31: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Blood Specimen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World 6-Year Perspective for Blood Specimen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Buccal Swabs & Hair Follicles Specimen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 35: World 6-Year Perspective for Buccal Swabs & Hair Follicles Specimen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 36: World Recent Past, Current & Future Analysis for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 37: World 6-Year Perspective for Other Specimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 40: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 41: USA 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 42: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 43: USA 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• CANADA
  • TABLE 46: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Canada 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 48: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 49: Canada 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 52: Canada Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 53: Canada 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• JAPAN
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 54: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 55: Japan 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 58: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Japan 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 60: Japan Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Japan 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• CHINA
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 64: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 65: China 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 66: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 67: China 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• EUROPE
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 70: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 71: Europe 6-Year Perspective for DNA & RNA Banking Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 72: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 73: Europe 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 76: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 77: Europe 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 78: Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 79: Europe 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• FRANCE
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 82: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 83: France 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 84: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 85: France 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• GERMANY
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 88: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 89: Germany 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 90: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 91: Germany 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 94: Germany Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 95: Germany 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• ITALY
  • TABLE 96: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 97: Italy 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 100: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 101: Italy 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 102: Italy Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 103: Italy 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• UNITED KINGDOM
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 106: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 107: UK 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 108: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 109: UK 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 113: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 115: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 119: Rest of Europe 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• ASIA-PACIFIC
  • DNA & RNA Banking Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 121: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 125: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 127: Asia-Pacific 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 128: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Service - Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of World 6-Year Perspective for DNA & RNA Banking Services by Service - Percentage Breakdown of Value Sales for Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage and Other Services for the Years 2025 & 2030
  • TABLE 130: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Application - Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 131: Rest of World 6-Year Perspective for DNA & RNA Banking Services by Application - Percentage Breakdown of Value Sales for Therapeutics Application, Drug Discovery & Clinical Research Application, Clinical Diagnostics Application and Other Applications for the Years 2025 & 2030
  • TABLE 132: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by End-Use - Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 133: Rest of World 6-Year Perspective for DNA & RNA Banking Services by End-Use - Percentage Breakdown of Value Sales for Academic Research End-Use, Pharma & Biotech Companies End-Use, Hospitals & Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • TABLE 134: Rest of World Recent Past, Current & Future Analysis for DNA & RNA Banking Services by Specimen - Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of World 6-Year Perspective for DNA & RNA Banking Services by Specimen - Percentage Breakdown of Value Sales for Blood Specimen, Buccal Swabs & Hair Follicles Specimen and Other Specimens for the Years 2025 & 2030

IV. COMPETITION